Japan CRISPR and CRISPR Associated Genes Market Insight
Published: 25 June 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
Japan CRISPR and CRISPR-associated genes market is projected to grow at a CAGR of 14.25% driven by rising gene-editing investments, expanding oncology research, increased adoption of CRISPR diagnostics, supportive regulations
Japan CRISPR and CRISPR Associated Genes Market Insights Forecasts to 2035
- The Japan CRISPR and CRISPR Associated Genes Market Size Was Estimated USD 142.8 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 14.25% from 2025 to 2035
- The Japan CRISPR and CRISPR Associated Genes Market Size is Expected to rise around USD 541.2 Million by 2035
Notable Insights for Japan crispr and crispr associated genes market
- The product-based segmentation indicates that the CRISPR-Cas9 Kits & Custom Guide RNA Modules segment holds a commanding position with almost 53% market share in the Japan CRISPR and CRISPR Associated Genes Market in 2025 due to its growing usage in fundamental academic research, pharmaceutical target discovery, and pre-clinical genetic engineering assays.
- The application-based segmentation shows that the Biomedical Research, Agricultural Biotechnology & Healthcare Diagnostics segment dominates with a market share of almost 59% in the Japan CRISPR and CRISPR Associated Genes Market in 2025 as a result of increased use of high-precision molecular analysis techniques and non-destructive gene characterization frameworks.
- The global revenue for Thermo Fisher Scientific Inc. in fiscal year 2025 was estimated at about $43.2 billion, driven by rising demand for advanced gene editing solutions, molecular laboratory equipment, and specialized life sciences analytical reagents.
- As per expectations, rising laboratory automation trends and AI-driven analytics along with industrial quality control needs will drive market expansion in which CRISPR sequence design technology increases gene-targeting precision up to 44% and reduces operational editing verification time up to 29%.
Download the eBook (ToC)
Research Methodologies Used to Analyze the Japan casein and caseinates market
The Japan CRISPR and CRISPR associated genes market is analyzed by a blend of primary and secondary research approaches for ensuring accurate information about the market and its forecasted performance. Primary research is conducted through discussions with equipment manufacturers and distributors, research laboratories, healthcare organizations, semiconductor firms, and experts to analyze demand trends, technological progress, and competitive activities. Secondary research will involve analyzing reports published by companies and governments, industry journals, scientific papers, import-export data, and industry organizations in connection with analytical instruments and photonics industries. Market estimation, trend analysis, and forecasting methods will be used for estimating market size, growth opportunities, price dynamics, and investments.
Decision advisory research methodology: Trusted insight for strategic decisions -making
What decisions advisory research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan CRISPR and CRISPR Associated Genes Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Japan CRISPR and CRISPR Associated Genes Market
- Thermo Fisher Scientific Inc.
- Merck KGaA (Japan Division)
- Takara Bio Inc.
- Integrated DNA Technologies, Inc. (IDT Japan)
- Agilent Technologies Japan, Ltd.
- Genscript Biotech Corporation
- Horizon Discovery (Revvity Japan)
- Lonza Japan LLC
- New England Biolabs Japan
- Sigma-Aldrich Japan
Recent Developments:
In January 2026, Takara Bio Inc. expanded its gene editing portfolio with AI-enabled CRISPR guide RNA design platforms optimized for high-throughput therapeutic screening and human cellular engineering research applications.
In August 2025, Thermo Fisher Scientific Inc. introduced next-generation custom Cas9 protein modules integrated with cloud-based cellular verification analytics tools for complex clinical diagnostics and targeted healthcare research.
Market Segmentation:
Japan CRISPR and CRISPR Associated Genes Market, By Product Type
- CRISPR-Cas9 Gene Editing Kits
- Custom Guide RNA (gRNA) Arrays
- Cas Proteins & Delivery Vectors
- CRISPR-Cas12 & Cas13 Diagnostic Kits
- Modified Genomic Editing Library Reagents
Japan CRISPR and CRISPR Associated Genes Market, By Technology Integration
- AI-Driven Off-Target Prediction Software
- Cloud-Integrated Lab Workflow Systems
- Automated Molecular Sequence Validation Platforms
- High-Resolution Cell Line Characterization Tools
- Real-Time Cleavage Processing Control Suites
Japan CRISPR and CRISPR Associated Genes Market, By Application
- Human Therapeutic Drug Discovery
- Agricultural Crop & Livestock Modification
- Clinical & Molecular Diagnostics Development
- Academic & Basic Genetic Research Projects
Expert Views:
The expansion of the CRISPR and CRISPR associated genes market in Japan will be facilitated by increased use of advanced genomic modification systems, an expanding volume of oncology research trials, and a high structural demand for highly localized precision therapeutics.The integration of AI-enabled sequence planning algorithms, high-efficiency chemical transport configurations, and automated validation tools will optimize molecular screening throughput and generate robust long-term demands across biopharmaceutical research centers, diagnostic clinical networks, and academic genomic infrastructure centers in Japan.
Author: Govind and Krishna By Decisions Advisors and Consulting